Infinity Pharmaceuticals

Infinity Pharmaceuticals LT Debt/Equity

The Long-Term Debt to Equity Ratio of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026 is 2.26. In the previous year, Long-Term Debt to Equity Ratio was -0.94 — a change of -340.87% (higher).

LT Debt/Equity

2.26

YoY

-340.87%

Last updated:

Long-Term Debt to Equity Ratio of Infinity Pharmaceuticals is 2021 2.26 . Long-Term Debt to Equity Ratio of Infinity Pharmaceuticals was 2020 -0.94 . It decreases by -340.87% higher compared to the previous year.

The Infinity Pharmaceuticals LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2014
0.00 USD
Jan 1, 2015
0.20 USD
Jan 1, 2016
0.23 USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
0.00 USD
Jan 1, 2019
3.83 USD
Jan 1, 2020
-0.94 USD
Jan 1, 2021
2.26 USD
The Infinity Pharmaceuticals LT Debt/Equity history
YEARLT Debt/EquityYoY
2.26-340.87%
-0.94-124.46%
3.83—
0.00—
0.00-100.00%
0.23+16.47%
0.20—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

Long-Term Debt to Equity Ratio of Infinity Pharmaceuticals is 2.26 in 2021.

Long-Term Debt to Equity Ratio of Infinity Pharmaceuticals changed from -0.94 to 2.26, representing a -340.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals